3.50
+7.03%
Close of 9 Nov 2026, in CAD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Optimi Health
Its shares trade on Canadian Securities Exchange under the ticker OPTI.CN. It has been listed since 25 February 2021. In the fiscal year to 30 September 2025, it reported revenue of C$426,301 and a net loss of C$3.7m. At that date it held total assets of C$15.2m and shareholders' equity of C$6.6m.
Optimi Health Corp. engages in the development, cultivation, extraction, processing, and distribution of functional mushrooms. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-02-25. The firm is a drug manufacturer and formulator licensed by Health Canada to produce and supply psychedelic substances, such as 3,4-Methylenedioxymethamphetamine (MDMA) and natural, Good Manufacturing Practice (GMP)-grade psilocybin, psilocin, and other psychedelic substances, some being synthetically formulated, as well as functional mushrooms that focus on domestic and international health and wellness markets. The firm owns approximately 20,000 technologically advanced manufacturing, cultivation and analytical facilities. The company also invests in in providing the supply of synthetic and natural psychedelics to the international market. The firm operates as a supplier of drug and nutraceutical products serving health food distributors, and drug developers and patients regulated by Health Canada.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 25 Feb 2021
- Employees
- 9
- Website
- optimihealth.ca ↗
Leadership
Pay as last reported
- Mr. James WilsonIndependent Chairman of the BoardC$108,500
- Mr. Dane StevensInterim Chief Executive Officer, Director, since 2020C$79,000
- Mr. Jacob SafarikChief Financial Officer, Director, since 2020C$135,250
- Mr. Bryan SafarikChief Operating Officer, Director, since 2020C$131,250
- Mr. Jonathan SchintlerIndependent DirectorC$43,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Optimi Health Corp. owns 20,000 advanced facilities for manufacturing and cultivation.
- The company is licensed by Health Canada to produce MDMA and psilocybin products.
- Optimi Health Corp. serves domestic and international health and wellness markets.
Weaknesses
- Optimi Health Corp. has only 9 employees as of 2021.
- The company's IPO was on 25 February 2021, a recent listing.
- Optimi Health Corp. operates in a highly regulated industry with strict Health Canada oversight.
Opportunities
- Optimi Health Corp. invests in supplying synthetic and natural psychedelics internationally.
- The firm targets health food distributors and drug developers in the wellness market.
- Optimi Health Corp. focuses on functional mushrooms for domestic and international markets.
Threats
- Health Canada regulations could restrict psychedelic substance production.
- The company faces competition in the functional mushroom market.
- Optimi Health Corp. must comply with international market supply regulations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.